The second installment of Jon M. Chu’s adaptation of the hit Broadway musical is slated to hit theaters in November.
Research and Development Expenses: Research and development expenses were $9.5 million for the full year 2024 compared to $4.7 million for the full year 2023. The increase of $4.8 million was ...
Attendees of CinemaCon have spotted the first poster for the highly anticipated second part of the Wicked movie, Wicked: For ...
Top-line results from SELVA, a Phase 3 single-arm, baseline-controlled trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel ...
Soap Central on MSN1d
“Won’t be as good as 1st…” – Fans laugh as the first poster for ‘Nobody 2’ drops. In theaters August 15Nobody 2 is set to release on August 15, 2025, and a first look was recently revealed. The poster features a cryptic image of ...
A new poster for Universal Pictures' Jurassic World Rebirth has been spotted in the wild at CinemaCon, and it gives us another look at the franchise's new "mutant" ...
President Donald Trump is using the power of the federal government to intimidate or neuter potential sources of opposition ...
One of my most highly-anticipated titles on the 2025 movie schedule is most definitely the highly anticipated Wicked: For ...
AVENGERS: DOOMSDAY - Bringing Back The Original X-MEN Might Be The Multiverse Saga's Biggest Mistake
Doomsday cast. Several of them were X-Men, but is it a mistake to shine a spotlight on that era of 20th Century Fox ...
Only one in three adults in the U.S. are compliant with the new recommendation, and many still think 50 is the age for a ...
Checkpoint Therapeutics, Inc. ("Checkpoint") (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced financial ...
UNLOXCYT™ (cosibelimab-ipdl) approved by U.S. FDA as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback